Form D · Pharmaceuticals

Ralexar Therapeutics, Inc.

Encinitas, CA · CIK 0001596494

Offering snapshot reported Apr 1, 2020 · SEC filing

Reported sold
$4.28M
Offering amount: $6M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 20, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.14M$4.28MJan 4, 2019: $1,888,964.00Jan 4, 2019Apr 1, 2020: $4,277,926.00Apr 1, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,888,964 → $4,277,926

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 1, 2020Amendment$4,277,926$2,388,962vs Jan 4, 201911SEC filing
Jan 4, 2019Initial$1,888,964No comparison11SEC filing
Jun 8, 2017Initial$4,145,191No comparison26SEC filing
Apr 28, 2015Amendment$10,600,000$5,440,000vs Jan 10, 201435SEC filing
Jan 10, 2014Initial$5,160,000No comparison32SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-329633

Source: Form D, filed Apr 1, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kamil Ali Jackson Executive
Douglas Gessl Executive
Jason Hong Director
Raju Mohan Executive
David Pfeiffer Director, Executive
Somasundaram Subramaniam Director
Somu Subramaniam Director
Stephen Tullman Director, Executive
Neal Walker Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
662 Encinitas Blvd. Suite 250
Encinitas, CA, 92024